Narval Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 9

Narval General Information

Description

Developer of antibody-like medical countermeasures designed for disease control in biodefense and biopharmaceutical applications. The company's platform uses artificial intelligence to design antibody mimetic proteins, enabling organizations to develop targeted therapeutic responses with enhanced precision and adaptability.

Contact Information

Website
www.narvalbio.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • Santo Tomas de Aquino 5715
  • Zapopan, Jalisco
  • Mexico
Primary Industry
Drug Discovery
Other Industries
Discovery Tools (Healthcare)
Other Healthcare Technology Systems
Biotechnology
Vertical(s)
Artificial Intelligence & Machine Learning, HealthTech, Life Sciences
Corporate Office
  • Santo Tomas de Aquino 5715
  • Zapopan, Jalisco
  • Mexico

Narval Timeline

202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Narval Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Accelerator/Incubator 01-May-2025 Completed Generating Revenue
6. Angel (individual) Completed Generating Revenue
5. Angel (individual) 22-Apr-2024 Completed Generating Revenue
4. Accelerator/Incubator 18-Mar-2024 Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2024 Completed Generating Revenue
2. Accelerator/Incubator 23-Aug-2023 Completed Generating Revenue
1. Accelerator/Incubator 26-Jul-2023 Completed Startup
To view Narval’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Narval Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of antibody-like medical countermeasures designed for disease control in biodefense and biopharmaceutical appl
Drug Discovery
Zapopan, Mexico
6 As of 2026

Cambridge, MA
 

Vancouver, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Narval Competitors (5)

One of Narval’s 5 competitors is Nabla Bio, a Venture Capital-Backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Nabla Bio Venture Capital-Backed Cambridge, MA
AbCellera Biologics Formerly VC-backed Vancouver, Canada
Absci Formerly VC-backed Vancouver, WA
Abalone Bio Venture Capital-Backed Emeryville, CA
Prothena Corporation Dublin, Ireland
You’re viewing 5 of 5 competitors. Get the full list »

Narval Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Narval Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Creative Destruction Lab Accelerator/Incubator
University of Toronto University
Angel (individual) Minority
Angel (individual) Minority
Angel (individual) Minority
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial

Narval FAQs

  • When was Narval founded?

    Narval was founded in 2023.

  • Where is Narval headquartered?

    Narval is headquartered in Zapopan, Mexico.

  • What is the size of Narval?

    Narval has 6 total employees.

  • What industry is Narval in?

    Narval’s primary industry is Drug Discovery.

  • Is Narval a private or public company?

    Narval is a Private company.

  • What is Narval’s current revenue?

    The current revenue for Narval is .

  • How much funding has Narval raised over time?

    Narval has raised $460K.

  • Who are Narval’s investors?

    Creative Destruction Lab, University of Toronto, , , and are 5 of 9 investors who have invested in Narval.

  • Who are Narval’s competitors?

    Nabla Bio, AbCellera Biologics, Absci, Abalone Bio, and Prothena are competitors of Narval.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process